Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.130
-0.090 (-4.05%)
At close: Dec 5, 2025, 4:00 PM EST
2.240
+0.110 (5.16%)
After-hours: Dec 5, 2025, 7:47 PM EST
Senti Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | - | - | 2.56 | 4.29 | 2.76 | 0.57 | Upgrade
|
| Revenue Growth (YoY) | - | - | -40.25% | 55.23% | 387.81% | 565.88% | Upgrade
|
| Cost of Revenue | 37.6 | 34.36 | 32.15 | 28.15 | 21.96 | 15.96 | Upgrade
|
| Gross Profit | -37.6 | -34.36 | -29.59 | -23.86 | -19.2 | -15.39 | Upgrade
|
| Selling, General & Admin | 22.26 | 19.92 | 34.85 | 38.23 | 21.25 | 9.3 | Upgrade
|
| Operating Expenses | 22.26 | 19.92 | 34.85 | 38.23 | 21.25 | 9.3 | Upgrade
|
| Operating Income | -59.86 | -54.28 | -64.44 | -62.08 | -40.45 | -24.69 | Upgrade
|
| Interest & Investment Income | 1.06 | 0.95 | 2.86 | 1.7 | 0.01 | 0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.2 | 18.07 | 3.3 | -0.03 | -0.12 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -47.6 | -35.26 | -58.28 | -60.42 | -40.56 | -24.65 | Upgrade
|
| Asset Writedown | - | -0.31 | -25.96 | - | -0.02 | -0.24 | Upgrade
|
| Other Unusual Items | 0.02 | -17.22 | 0.83 | 10.75 | -14.74 | 5.03 | Upgrade
|
| Pretax Income | -47.58 | -52.79 | -83.41 | -49.67 | -55.32 | -19.86 | Upgrade
|
| Earnings From Continuing Operations | -47.58 | -52.79 | -83.41 | -49.67 | -55.32 | -19.86 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 12.35 | -8.55 | - | - | Upgrade
|
| Net Income | -47.58 | -52.79 | -71.06 | -58.21 | -55.32 | -19.86 | Upgrade
|
| Preferred Dividends & Other Adjustments | 2.52 | 2.52 | - | - | - | - | Upgrade
|
| Net Income to Common | -50.1 | -55.31 | -71.06 | -58.21 | -55.32 | -19.86 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 5 | 4 | 3 | 0 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 5 | 4 | 3 | 0 | 1 | Upgrade
|
| Shares Change (YoY) | 269.32% | 3.58% | 69.93% | 796.58% | -78.99% | 2.03% | Upgrade
|
| EPS (Basic) | -2.98 | -12.03 | -16.01 | -22.29 | -189.95 | -14.33 | Upgrade
|
| EPS (Diluted) | -2.98 | -12.03 | -16.01 | -22.29 | -189.95 | -14.33 | Upgrade
|
| Free Cash Flow | -50.28 | -41.42 | -64.43 | -76.27 | -40.18 | -25.33 | Upgrade
|
| Free Cash Flow Per Share | -2.99 | -9.01 | -14.52 | -29.21 | -137.96 | -18.27 | Upgrade
|
| Operating Margin | - | - | -2516.28% | -1448.53% | -1464.90% | -4362.90% | Upgrade
|
| Profit Margin | - | - | -2774.62% | -1358.14% | -2003.59% | -3509.19% | Upgrade
|
| Free Cash Flow Margin | - | - | -2515.93% | -1779.51% | -1455.20% | -4475.97% | Upgrade
|
| EBITDA | -56.18 | -50.44 | -60.88 | -60.69 | -39.68 | -24.13 | Upgrade
|
| D&A For EBITDA | 3.68 | 3.84 | 3.56 | 1.4 | 0.77 | 0.56 | Upgrade
|
| EBIT | -59.86 | -54.28 | -64.44 | -62.08 | -40.45 | -24.69 | Upgrade
|
| Revenue as Reported | - | - | 2.56 | 4.29 | 2.76 | 0.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.